Advarra offers the most comprehensive approach to Phase I research with experience overseeing thousands of Phase I studies in the US and Canada.
In this webinar, Michele Russell-Einhorn, JD, Advarra's CCO and IO, and Judith Carrithers, JD, Advarra's Director of Regulatory Affairs, discuss FAQs and common issues in implementing the revised Common Rule.
Judith Carrithers, JD, Director of Regulatory Services at Advarra, and Michele Russell-Einhorn, JD, Chief Compliance Officer and Institutional Official at Advarra, discuss a checklist of action items to consider and…
Luke Gelinas, PhD, IRB Chair at Advarra, discusses some of the oversight challenges presented by PCOR and shares policy recommendations for managing such challenges.
Advarra’s Canadian review service combines local, expert oversight with streamlined processes and the most extensive site reach in Canada to aid you in the conduct of efficient, responsible research.
Advarra serves as your external support and compliance partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
Advarra provides flexible solutions that help accelerate the initial IRB review process and make it more efficient.
Advarra’s Central Oncology Review service provides robust human subject protections review that cancer research institutions expect.
In this webinar, presenters from Ropes & Gray LLP provide an introduction to the GDPR and its potential application to the US-based research community.
Presenters from Advarra and Verrill Dana, LLP, provide an overview of the current state of the FDA’s Expanded Access Program and state and federal “Right to Try” legislative efforts.